These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2895302)

  • 1. Immunosuppressive effect of pneumococcal vaccine contaminated with blood-group-A-like substance.
    Nurmi T; Koskela P
    Lancet; 1988 Apr; 1(8588):771. PubMed ID: 2895302
    [No Abstract]   [Full Text] [Related]  

  • 2. Blood group A substances are not present in currently available pneumococcal vaccine.
    Nalin DR; Morges W
    Vaccine; 1988 Dec; 6(6):469-70. PubMed ID: 3245290
    [No Abstract]   [Full Text] [Related]  

  • 3. Blood-group-A-like substance in a preparation of pneumococcal vaccine.
    Siber GR; Ambrosino DM; Gorgone BC
    Ann Intern Med; 1982 May; 96(5):580-6. PubMed ID: 7073150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine related glomerulonephritis.
    Tan SY; Cumming AD
    BMJ; 1993 Jan; 306(6872):248. PubMed ID: 8443526
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-A isoagglutinins and pneumococcal vaccine.
    Noël A
    Lancet; 1981 Sep; 2(8248):687-8. PubMed ID: 6116059
    [No Abstract]   [Full Text] [Related]  

  • 6. Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups.
    Robbins JB; Austrian R; Lee CJ; Rastogi SC; Schiffman G; Henrichsen J; Mäkelä PH; Broome CV; Facklam RR; Tiesjema RH
    J Infect Dis; 1983 Dec; 148(6):1136-59. PubMed ID: 6361173
    [No Abstract]   [Full Text] [Related]  

  • 7. Strangles in horses can be caused by vaccination with Pinnacle I. N.
    Cursons R; Patty O; Steward KF; Waller AS
    Vaccine; 2015 Jul; 33(30):3440-3. PubMed ID: 26025806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reformulated Pneumovax available.
    Krakowshi FM; Santopolo AC
    Am Fam Physician; 1982 Jun; 25(6):50. PubMed ID: 7081010
    [No Abstract]   [Full Text] [Related]  

  • 9. Blood group substances in pneumococcal vaccine.
    Nalin DR; Morges W
    Lancet; 1988 Sep; 2(8612):695. PubMed ID: 2901561
    [No Abstract]   [Full Text] [Related]  

  • 10. Pneumococcal vaccine.
    Med Lett Drugs Ther; 1999 Sep; 41(1061):84. PubMed ID: 10505073
    [No Abstract]   [Full Text] [Related]  

  • 11. Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines.
    Poolman J; Borrow R
    Expert Rev Vaccines; 2011 Mar; 10(3):307-22. PubMed ID: 21434799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenic protein contaminants in pneumococcal vaccines.
    Yu J; Briles DE; Englund JA; Hollingshead SK; Glezen WP; Nahm MH
    J Infect Dis; 2003 Mar; 187(6):1019-23. PubMed ID: 12660950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumococcal vaccine.
    Med Lett Drugs Ther; 1980 Dec; 22(26):114. PubMed ID: 7453667
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pneumococcal vaccination--yes or no?].
    Hess T
    Schweiz Med Wochenschr; 1998 Jul; 128(27-28):1096-103. PubMed ID: 9691344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult pneumococcal vaccination guideline. SAMA-SA Pulmonology Society Working Group.
    S Afr Med J; 1999 Nov; 89(11 Suppl):1222-30. PubMed ID: 10599303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Planning for a second (23 valent) generation pneumococcal vaccine. With special reference to new developments in our understanding of the structure and biology of polysaccharides.
    Robbins JB; Schneerson R
    Bull Eur Physiopathol Respir; 1983; 19(2):215-26. PubMed ID: 6347282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pneumococcal vaccine in children and young adults with chronic renal disease.
    Fuchshuber A; Kühnemund O; Keuth B; Lütticken R; Michalk D; Querfeld U
    Nephrol Dial Transplant; 1996 Mar; 11(3):468-73. PubMed ID: 8671817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of vaccinations in patients with cryopyrin-associated periodic syndromes: a prospective registry based study.
    Jaeger VK; Hoffman HM; van der Poll T; Tilson H; Seibert J; Speziale A; Junge G; Franke K; Vritzali E; Hawkins PN; Kuemmerle-Deschner J; Walker UA
    Rheumatology (Oxford); 2017 Sep; 56(9):1484-1491. PubMed ID: 28482054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe exacerbation of systemic lupus erythematosus after hepatitis B vaccination and importance of pneumococcal vaccination in patients with autosplenectomy: comment on the article by Battafarano et al.
    Senécal JL; Bertrand C; Coutlée F
    Arthritis Rheum; 1999 Jun; 42(6):1307-8. PubMed ID: 10366133
    [No Abstract]   [Full Text] [Related]  

  • 20. Adverse reactions to pneumococcal polysaccharide vaccine in children.
    Halsey NA; Spika JS; Lum GM; Schiffman GS; Lauer BA
    Pediatr Infect Dis; 1982; 1(1):34-6. PubMed ID: 7177893
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.